Hi @RaceOncology
Congratulations again.
In the breast cancer preclinical, synergy with several anthracyclines was tested.
However, in this preclinical, rescue from only one anthracycline, namely doxorubicin, was tested.
My question is: how do we know that the cardio-protective effect of Zantrene will be repeated with anthracyclines other than doxorubicin?
Thanks
II
- Forums
- ASX - By Stock
- RAC
- Ann: Breakthrough Zantrene Heart Protection Discovery
Ann: Breakthrough Zantrene Heart Protection Discovery, page-107
-
-
- There are more pages in this discussion • 260 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.50 |
Change
0.055(3.82%) |
Mkt cap ! $245.3M |
Open | High | Low | Value | Volume |
$1.46 | $1.50 | $1.46 | $50.72K | 34.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6138 | $1.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 1400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6138 | 1.480 |
1 | 1050 | 1.475 |
1 | 1050 | 1.470 |
2 | 3076 | 1.465 |
1 | 1050 | 1.460 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 1400 | 1 |
1.505 | 1187 | 1 |
1.510 | 684 | 1 |
1.515 | 5556 | 1 |
1.520 | 1800 | 1 |
Last trade - 10.10am 12/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |